Apellis Pharmaceuticals reports Q4 results
Source: SeekingAlpha
2026-02-24 07:09:19 ET
More on Apellis Pharmaceuticals
- Apellis Pharmaceuticals, Inc. (APLS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Apellis Pharmaceuticals, Inc. (APLS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Apellis Pharmaceuticals: A Good Product That Just Misses The Mark
- Apellis Pharmaceuticals Q4 2025 Earnings Preview
- TTM Technologies, Dutch Bros to join S&P 400 Index; Amneal, Apellis to be part of S&P SmallCap 600
Read the full article on Seeking Alpha
For further details see:
Apellis Pharmaceuticals reports Q4 results
Apellis Pharmaceuticals Inc.
NASDAQ: APLS
APLS Trading
-2.96% G/L:
$20.99 Last:
478,850 Volume:
$21.30 Open:
APLS Latest News
February 24, 2026 07:05:00 am
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026 07:00:00 am
Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference
APLS Stock Data
$2,869,591,944
89,501,409
1.5%
87
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
